Gen-Hyal® is a Prigen registered trademark. Prigen is an Italian company founded in 2003 by a team of scientists with expertise in the fields of biotechnology, pharmaceuticals, molecular diagnostics and dermocosmetics.

Prigen’s scientists developed a new dermocosmetic line of products based on technologically advanced formulations, according to the concept of ESSENTIALITY: very few ingredients in maximized concentrations in the absence of PEG, EDTA, silicones and parabens.

The mission of Gen-Hyal® is to prevent and counteract the effects of skin aging, supporting and improving the health of the skin, thanks to the development of essential and non-aggressive formulations able to offer the correct supply of active ingredients every day and reduce the use of potential allergenic agents.

As part of the research projects, our team of scientists has developed and patented an innovative technology – the Glycerosomal Technology – for the controlled release of active substances for topical use in both the medical and dermocosmetic sectors.

This technology is able to improve and increase the delivery of the active ingredient from 3 to 5 times compared to formulations that do not contain it. It is a liposome-like technology that makes topical formulations significantly more performing from the point of view of the efficacy, stability and safety of the formula.